Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

302
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
302
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

251
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
251
Analgesia and Pain Management01:25

Analgesia and Pain Management

625
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
625
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

860
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
860
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

205
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
205
Drug Classes and Categories01:25

Drug Classes and Categories

2.0K
Drugs can be classified according to their chemical composition or their intended therapeutic application. For instance, anti-infective agents that possess the ability to eliminate pathogens or suppress their growth and reproduction can be grouped based on the organisms they target or their chemical structure. Furthermore, drugs can be divided into prescription, nonprescription, or controlled substances. Prescription medications, such as antibiotics, require oversight from a licensed healthcare...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimizing antidepressant use in geriatric depression: expert consensus from French societies of geriatrics, old age psychiatry, and clinical pharmacy (SFGG, SF3PA, and SFPC).

European psychiatry : the journal of the Association of European Psychiatrists·2026
Same author

GHSR agonism increases blood glucose but delays food intake in GHSR hyperresponsive rats.

Journal of neuroendocrinology·2026
Same author

Traumatic-like fear memory recall causes persistent morphine conditioned place preference in drug withdrawn male mice.

Progress in neuro-psychopharmacology & biological psychiatry·2026
Same author

Stereodivergent Hydrohalogenation of SCF<sub>3</sub> Alkynes and Cross- Coupling Reactions.

Organic letters·2024
Same author

Photocatalyzed Cascade Hydrogen Atom Transfers for Assembly of Multi-Substituted α-SCF<sub>3</sub> and α-SCF<sub>2</sub>H Cyclopentanones.

Angewandte Chemie (International ed. in English)·2024
Same author

Behavioral sensitization to psychostimulants and opioids: What is known in rodents and what still needs to be explored in humans?

Progress in neuro-psychopharmacology & biological psychiatry·2023

Related Experiment Video

Updated: Jul 7, 2025

Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs
10:13

Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs

Published on: November 8, 2024

2.2K

Oxycodone, an opioid like the others?

Nicolas Marie1, Florence Noble1

  • 1Université Paris Cité, CNRS, Inserm, Pharmacologie et Thérapies des Addictions, Paris, France.

Frontiers in Psychiatry
|December 28, 2023
PubMed
Summary

Oxycodone is a major driver of the North American opioid crisis. This review explores genomic and epigenetic differences between oxycodone and other opioids, aiming to explain varied responses in addiction models.

Keywords:
addictionepigeneticsgene regulationsmorphineopioidsoxycodonepreclinical studies

More Related Videos

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
07:23

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

Published on: July 29, 2014

33.4K
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

9.7K

Related Experiment Videos

Last Updated: Jul 7, 2025

Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs
10:13

Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs

Published on: November 8, 2024

2.2K
Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
07:23

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

Published on: July 29, 2014

33.4K
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

9.7K

Area of Science:

  • Pharmacology
  • Neuroscience
  • Genetics

Background:

  • Opioid analgesics, particularly oxycodone, are central to the North American addiction crisis.
  • Oxycodone has been identified as a primary contributor to opioid use disorder in the USA from 1999-2016.
  • Research on oxycodone's preclinical effects is rapidly expanding.

Purpose of the Study:

  • To compare the genomic and epigenetic regulatory features of oxycodone with other opioid agonists.
  • To discuss potential differences in pharmacological responses to various opioids, especially after repeated administration.
  • To explore these differences in preclinical models relevant to drug dependence potential.

Main Methods:

  • Literature review focusing on preclinical studies.
  • Comparative analysis of genomic and epigenetic data related to opioid agonists.
  • Examination of pharmacological responses in addiction models.

Main Results:

  • Oxycodone is frequently compared to other opioids for analgesic properties.
  • Growing body of preclinical research highlights oxycodone's role in opioid use disorder.
  • Differences in genomic and epigenetic regulation may underlie varied opioid responses.

Conclusions:

  • Understanding genomic and epigenetic factors is crucial for differentiating opioid effects.
  • This comparative approach may elucidate mechanisms behind varying drug dependence potential.
  • Further research into these regulatory features can inform strategies to address the opioid crisis.